PMR’s Global Microbial Fermentation CMO Market Analysis is Based on Increasing Demand for Biopharmaceuticals and Focus on Sustainability and Green Technologies
Report ID: PMRREP34615
Number of Pages: 210
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: July-2024
1. Executive Summary
1.1. Global Microbial Fermentation CMO Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 – 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Value Chain Analysis
3.3. Key Deals and Mergers
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Global Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023–2031
4.3. Global Microbial Fermentation CMO Market Outlook: Type of Expression Systems
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Type of Expression Systems, 2018 – 2022
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
4.3.3.1. Bacterial Expression Systems
4.3.3.2. Yeast Expression Systems
4.3.3.3. Others
4.4. Market Attractiveness Analysis: Type of Expression Systems
4.5. Global Microbial Fermentation CMO Market Outlook: Type of Biologics
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Type of Biologics, 2018 – 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
4.5.3.1. Enzymes
4.5.3.2. Antibodies
4.5.3.3. Plasmid DNA
4.5.3.4. Recombinant Proteins
4.5.3.5. Others
4.6. Market Attractiveness Analysis: Type of Biologics
4.7. Global Microbial Fermentation CMO Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 – 2022
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
4.7.3.1. Biopharma Companies
4.7.3.2. Academic & Research Institutes
4.7.3.3. Others
4.8. Market Attractiveness Analysis: End User
5. Global Microbial Fermentation CMO Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 – 2022
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 – 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
6.2.1. By Country
6.2.2. By Type of Expression Systems
6.2.3. By Type of Biologics
6.2.4. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
6.4.1. Bacterial Expression Systems
6.4.2. Yeast Expression Systems
6.4.3. Others
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
6.5.1. Enzymes
6.5.2. Antibodies
6.5.3. Plasmid DNA
6.5.4. Recombinant Proteins
6.5.5. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
6.6.1. Biopharma Companies
6.6.2. Academic & Research Institutes
6.6.3. Others
6.7. Market Attractiveness Analysis
7. Europe Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
7.2.1. By Country
7.2.2. By Type of Expression Systems
7.2.3. By Type of Biologics
7.2.4. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
7.4.1. Bacterial Expression Systems
7.4.2. Yeast Expression Systems
7.4.3. Others
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
7.5.1. Enzymes
7.5.2. Antibodies
7.5.3. Plasmid DNA
7.5.4. Recombinant Proteins
7.5.5. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
7.6.1. Biopharma Companies
7.6.2. Academic & Research Institutes
7.6.3. Others
7.7. Market Attractiveness Analysis
8. East Asia Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
8.2.1. By Country
8.2.2. By Type of Expression Systems
8.2.3. By Type of Biologics
8.2.4. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
8.4.1. Bacterial Expression Systems
8.4.2. Yeast Expression Systems
8.4.3. Others
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
8.5.1. Enzymes
8.5.2. Antibodies
8.5.3. Plasmid DNA
8.5.4. Recombinant Proteins
8.5.5. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
8.6.1. Biopharma Companies
8.6.2. Academic & Research Institutes
8.6.3. Others
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
9.2.1. By Country
9.2.2. By Type of Expression Systems
9.2.3. By Type of Biologics
9.2.4. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
9.4.1. Bacterial Expression Systems
9.4.2. Yeast Expression Systems
9.4.3. Others
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
9.5.1. Enzymes
9.5.2. Antibodies
9.5.3. Plasmid DNA
9.5.4. Recombinant Proteins
9.5.5. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
9.6.1. Biopharma Companies
9.6.2. Academic & Research Institutes
9.6.3. Others
9.7. Market Attractiveness Analysis
10. Latin America Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
10.2.1. By Country
10.2.2. By Type of Expression Systems
10.2.3. By Type of Biologics
10.2.4. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
10.4.1. Bacterial Expression Systems
10.4.2. Yeast Expression Systems
10.4.3. Others
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
10.5.1. Enzymes
10.5.2. Antibodies
10.5.3. Plasmid DNA
10.5.4. Recombinant Proteins
10.5.5. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
10.6.1. Biopharma Companies
10.6.2. Academic & Research Institutes
10.6.3. Others
10.7. Market Attractiveness Analysis
11. Middle East & Africa Microbial Fermentation CMO Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
11.2.1. By Country
11.2.2. By Type of Expression Systems
11.2.3. By Type of Biologics
11.2.4. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Expression Systems, 2023 – 2031
11.4.1. Bacterial Expression Systems
11.4.2. Yeast Expression Systems
11.4.3. Others
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type of Biologics, 2023 – 2031
11.5.1. Enzymes
11.5.2. Antibodies
11.5.3. Plasmid DNA
11.5.4. Recombinant Proteins
11.5.5. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
11.6.1. Biopharma Companies
11.6.2. Academic & Research Institutes
11.6.3. Others
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Structure
12.1.1. Competition Intensity Mapping By Market
12.1.2. Competition Dashboard
12.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.2.1. AbbVie Inc.
12.2.1.1. Overview
12.2.1.2. Segments and Products
12.2.1.3. Key Financials
12.2.1.4. Market Developments
12.2.1.5. Market Strategy
12.2.2. BOC Sciences
12.2.2.1. Overview
12.2.2.2. Segments and Products
12.2.2.3. Key Financials
12.2.2.4. Market Developments
12.2.2.5. Market Strategy
12.2.3. Eurofins Scientific
12.2.3.1. Overview
12.2.3.2. Segments and Products
12.2.3.3. Key Financials
12.2.3.4. Market Developments
12.2.3.5. Market Strategy
12.2.4. FUJIFILM Diosynth Biotechnologies
12.2.4.1. Overview
12.2.4.2. Segments and Products
12.2.4.3. Key Financials
12.2.4.4. Market Developments
12.2.4.5. Market Strategy
12.2.5. GSK plc
12.2.5.1. Overview
12.2.5.2. Segments and Products
12.2.5.3. Key Financials
12.2.5.4. Market Developments
12.2.5.5. Market Strategy
12.2.6. Lonza Group AG
12.2.6.1. Overview
12.2.6.2. Segments and Products
12.2.6.3. Key Financials
12.2.6.4. Market Developments
12.2.6.5. Market Strategy
12.2.7. Sandoz Group AG
12.2.7.1. Overview
12.2.7.2. Segments and Products
12.2.7.3. Key Financials
12.2.7.4. Market Developments
12.2.7.5. Market Strategy
12.2.8. WuXi Biologics
12.2.8.1. Overview
12.2.8.2. Segments and Products
12.2.8.3. Key Financials
12.2.8.4. Market Developments
12.2.8.5. Market Strategy
12.2.9. Evonik Industries
12.2.9.1. Overview
12.2.9.2. Segments and Products
12.2.9.3. Key Financials
12.2.9.4. Market Developments
12.2.9.5. Market Strategy
12.2.10. DSM
12.2.10.1. Overview
12.2.10.2. Segments and Products
12.2.10.3. Key Financials
12.2.10.4. Market Developments
12.2.10.5. Market Strategy
12.2.11. Sekisui Diagnostics
12.2.11.1. Overview
12.2.11.2. Segments and Products
12.2.11.3. Key Financials
12.2.11.4. Market Developments
12.2.11.5. Market Strategy
12.2.12. AGC Biologics
12.2.12.1. Overview
12.2.12.2. Segments and Products
12.2.12.3. Key Financials
12.2.12.4. Market Developments
12.2.12.5. Market Strategy
12.2.13. BIOVECTRA
12.2.13.1. Overview
12.2.13.2. Segments and Products
12.2.13.3. Key Financials
12.2.13.4. Market Developments
12.2.13.5. Market Strategy
12.2.14. Avid Bioservices
12.2.14.1. Overview
12.2.14.2. Segments and Products
12.2.14.3. Key Financials
12.2.14.4. Market Developments
12.2.14.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
